@R2Discovery on Lumibird SA (LBIRD.PA)

主要经营地 法国

详细生意模式 Lumibird SA是军事光子学leader，设计、制造、销售various lasers用于科学、工业、医疗应用，分为Photonics和Medical两个部门。Photonics部门focus军事rangefinders用于多个平台：Dassault Rafale战斗机、Rheinmetall车辆及其他military systems。公司提供sophisticated anti-UAV systems关键技术。Hidden asset story：significant Cilas stake(anti-UAV company与Safran、Thales、MDBA合作)。Defense currently <20% sales，post medical disposal(~50% sales)后set to grow significantly。Over 60年military rangefinder制造经验，5000+ long-range rangefinders已交付30+国家。

护城河 🟡

估值水平 EV/EBITDA 18.328

EV/Market Cap EV $562.47M / Market Cap $477.87M

网络观点 作者认为欧洲sovereign play undiscovered。Lumibird是military photonics leader，rangefinders用于Dassault Rafale、Rheinmetall vehicles等。关键tech for sophisticated anti-UAV systems。Hidden asset：significant Cilas stake(anti-UAV，与Safran、Thales、MDBA)。Defense <20% sales现在，post medical disposal(50% sales)后set to grow significantly。交易12x EBITDA。

AI观点 Lumibird SA(EPA:LBIRD)是光子学和医疗激光设备制造商，总部Lannion France，Paris stock exchange上市。Photonics部门leader in military applications offering rangefinders across scientific、industrial、medical。公司于2022年收购SAAB defense laser rangefinder business，可leverage 60年+military rangefinder制造经验。5000+ long-range laser rangefinders delivered to 30+国家。Multi-domain laser rangefinders designed and approved用于naval、land、airborne applications requiring low-hazard functionality combined with high performance，基于solid-state laser technology operating at eye-safe 1.5µm wavelength。产品包括OdiPro和VIDAR系统，recent major contracts with Saab、BAE Systems和various NATO countries用于combat vehicles、naval fire control systems、air defense platforms。Medical部门经营laser医疗设备。Defense currently small sales share，potential growth if medical disposal proceeds。